Media, Inc. News: CytoDyn, Treatment Conference-Bound


Mississauga, ON -- (SBWIRE) -- 02/28/2019 -- Media, Inc. ( announces its latest article titled "CytoDyn, Treatment Conference-Bound."

Companies mentioned in this article include CytoDyn Inc. (OTC:CYDY).

Article Excerpt:

It's certainly creating a great deal of hype, and investors and the medical community alike are hoping it's not hype that turns into hyperbole.

Vancouver, Wash.-based CytoDyn Inc. (OTC:CYDY) shook things up Wednesday among medical research types, on word the late-stage biotechnology company is scheduled in early March to present its latest discovery at the Conference on Retroviruses and Opportunistic Infections in Seattle.

The full version of this article can be found at:

About is focused on the small-cap / penny stock market and has become a reputable name in the investment community. runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor. also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria looks for includes strong revenues, a seasoned management, innovative business plans, among many others. also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here:

Contact: Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: /

Note: has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: